9 HR Daytrana 1.67 MG/HR Transdermal System
- RxCUI
- 753439
- RxNorm name
- 9 HR Daytrana 1.67 MG/HR Transdermal System
- Display name
- 9 HR Daytrana 1.67 MG/HR Transdermal System
- Full name
- 9 HR Daytrana 1.67 MG/HR Transdermal System
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:51
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daytrana | METHYLPHENIDATE | Noven Therapeutics, LLC | 2c312c31-3198-4775-91ab-294e0b4b9e7f | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | 753439 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2c312c31-3198-4775-91ab-294e0b4b9e7f | Daytrana 15 MG/9HR Transdermal System [PSN] · 9 HR methylphenidate 1.67 MG/HR Transdermal System [Daytrana] [SBD] · 9 HR Daytrana 1.67 MG/HR Transdermal System [SY] · Daytrana 15 MG per 9HR Transdermal Patch [SY] · Daytrana 15 MG/9HR Transdermal System [SY] | 5 | 29 | These highlights do not include all the information needed to use DAYTRANA ® safely and effectively. See full prescribing information for DAYTRANA. DAYTRANA ® (methylphenidate transdermal system), CII Initial U.S. Approval: 2006 | 20250901 |